0001239819-23-000006.txt : 20230104
0001239819-23-000006.hdr.sgml : 20230104
20230104171252
ACCESSION NUMBER: 0001239819-23-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VITALE MARY BETH
CENTRAL INDEX KEY: 0001186863
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52008
FILM NUMBER: 23507846
MAIL ADDRESS:
STREET 1: 821 17TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LUNA INNOVATIONS INC
CENTRAL INDEX KEY: 0001239819
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 FIRST STREET SW
STREET 2: SUITE 200
CITY: ROANOKE
STATE: VA
ZIP: 24011
BUSINESS PHONE: 540-769-8400
MAIL ADDRESS:
STREET 1: 301 FIRST STREET SW
STREET 2: SUITE 200
CITY: ROANOKE
STATE: VA
ZIP: 24011
4
1
wf-form4_167287031677087.xml
FORM 4
X0306
4
2023-01-03
0
0001239819
LUNA INNOVATIONS INC
LUNA
0001186863
VITALE MARY BETH
C/O LUNA INNOVATIONS INCORPORATED
301 1ST STREET, SW, SUITE 200
ROANOKE
VA
24011
1
0
0
0
Stock Units
2023-01-03
4
A
0
1167.96
0
A
Common Stock
1167.96
49476.89
D
Stock Units
2023-01-03
4
A
0
305.90
0
A
Common Stock
305.9
49782.79
D
Stock Units
2023-01-03
4
A
0
139.04
0
A
Common Stock
139.04
49921.83
D
Stock Units
2023-01-03
4
A
0
139.04
0
A
Common Stock
139.04
50060.87
D
Stock Units are convertible into issuer's common stock on a 1-for-1 basis.
This grant was made pursuant to the issuer's non-employee director compensation, as compensation for Ms. Vitale's service as a member of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $10,500.00 divided by $8.99, the closing price of the issuer's common stock on the Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.
The stock units become issuable in common stock of the issuer at the election of the Reporting Person upon the earliest to occur of the Reporting Person's termination of service, a change in control of the issuer, an unforeseeable emergency, or a fixed date selected by the Reporting Person. The units have no expiration date.
This grant was made pursuant to issuer's non-employee director compensation policy, as compensation for Ms. Vitale's service as the chair of the nominating and governance committee of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $2,750.00 divided by $8.99, the closing price of issuer's common stock on the Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.
This grant was made pursuant to the issuer's non-employee director compensation policy, as compensation for Ms. Vitale's service on the audit committee of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $1,250.00 divided by $8.99, the closing price of issuer's common stock on Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.
This grant was made pursuant to the issuer's non-employee director compensation policy, as compensation for Ms. Vitale's service on the risk committee of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $1,250.00 divided by $8.99, the closing price of issuer's common stock on Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.
/s/ Scott A. Graeff, Attorney-In-Fact
2023-01-04